Sign in
BDXA Stock Price, Chart, Stats & News
Becton, Dickinson and Company
Save
Becton, Dickinson and Company (BDXA) does not currently pay a dividend.
55.91B
Market cap
45.70x
Current P/E
–
Forward P/E
BDXA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 45.76% |
Operating margin | 12.40% |
Pretax margin | 9.41% |
Net margin | 8.01% |
Effective tax rate | 14.83% |
ROA | 3.20% |
ROE | 6.93% |
D/E | 0.77x |
Interest coverage ratio | 4.81x |
BDXA valuation
P/E | 45.70x |
P/S | 2.55x |
P/B | 1.74x |
P/CF | 12.98x |
P/FCF | 21.28x |
P/OCF | 12.98x |
PEG | 5.05x |
EV multiple | 7.35x |
About
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world.
Similar securities
Based on sector and market capitalization
Report issue